title: The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
abstract: BACKGROUND
  Risk prediction models may be valuable to identify women at risk of pre-eclampsia to guide aspirin prophylaxis in early pregnancy.
  
  
  OBJECTIVE
  To assess the performance of 'simple' risk models for pre-eclampsia that use routinely collected maternal characteristics; compare with 'specialised' models that include specialised tests; and to guideline recommended decision rules.
  
  
  METHODS
  MEDLINE, Embase and PubMed were searched to June 2014.
  
  
  METHODS
  We included studies that developed or validated pre-eclampsia risk models using maternal characteristics with or without specialised tests and reported model performance.
  
  
  METHODS
  We extracted data on study characteristics; model predictors, validation and performance including area under the curve (AUC), sensitivity and specificity.
  
  
  RESULTS
  We identified 29 studies that developed 70 models including 22 simple models. Studies included 151-9149 women with a pre-eclampsia prevalence of 1.2-9.5%. No single predictor was included in all models. Four simple models were externally validated, with a model using parity, pre-eclampsia history, race, chronic hypertension and conception method to predict early-onset pre-eclampsia achieving the highest AUC (0.76, 95% CI 0.74-0.77). Nine studies comparing simple versus specialized models in the same population reported AUC favouring specialised models. A simple model achieved fewer false positives than a guideline recommended risk factor list, but sensitivity to classify risk for aspirin prophylaxis was not assessed.
  
  
  CONCLUSIONS
  Validated simple pre-eclampsia risk models demonstrate good risk discrimination that can be improved with specialised tests. Further research is needed to determine their clinical value to guide aspirin prophylaxis compared with decision rules.
  
  
  CONCLUSIONS
  Pre-eclampsia risk models using maternal factors show good risk discrimination to guide aspirin prophylaxis.
authors.affiliation: School of Medicine, The University of Notre Dame Australia, Sydney, NSW, Australia.
authors.forename: Zta
authors.initials: Z
authors.lastname: Al-Rubaie
authors.affiliation: NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
authors.forename: L M
authors.initials: LM
authors.lastname: Askie
authors.affiliation: Departments of Medicine, Health Policy Management and Evaluation, and Obstetrics and Gynecology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
authors.forename: J G
authors.initials: JG
authors.lastname: Ray
authors.affiliation: NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.|Department of Statistics, Macquarie University, Sydney, NSW, Australia.
authors.forename: H M
authors.initials: HM
authors.lastname: Hudson
authors.affiliation: School of Medicine, The University of Notre Dame Australia, Sydney, NSW, Australia.|NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
authors.forename: S J
authors.initials: SJ
authors.lastname: Lord
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D001794:Blood Pressure; D003661:Decision Support Techniques; D005260:Female; D005306:Fertilization; D006801:Humans; D006973:Hypertension / Q000453:epidemiology*; D015233:Models, Statistical; D010298:Parity; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011225:Pre-Eclampsia / Q000453:epidemiology* / Q000378:metabolism / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000453:epidemiology; D011266:Pregnancy-Associated Plasma Protein-A / Q000378:metabolism; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods*; D018608:Ultrasonography, Doppler; D055988:Uterine Artery / Q000000981:diagnostic imaging
chemical_list: D010975:Platelet Aggregation Inhibitors; D011266:Pregnancy-Associated Plasma Protein-A; D001241:Aspirin
keywords: Aspirin; pre-eclampsia; risk factors; risk prediction models; systematic review; validation